Fasting: Clinical Trials

7 trials for Fasting, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed. 7 Phase 2, 2 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 27Completed 7
Phase 12Completed 2
Phase 31Completed 1

Follow Fasting: new trials by email Literature Review of Fasting trials Research Report on Fasting

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pivotal BE Study of TAH3311 ODF vs ELIQUIS® Tablet Under Fasted Condition in Healthy Volunteers
5 mg Apixaban Oral Dissolving Film (fasting), 5 mg Apixaban Oral Dissolving Film (fed), 5 mg Apixaban Oral Tablet (US RS/RLD) - Random Allocation, Intermittent Fasting
Phase 2CompletedTAHO Pharmaceuticals Ltd.602024-11-162025-04-11
Proton Pump Inhibitors Effects on Dyspepsia During Ramadan Fasting
Esomeprazole, Placebo - Dyspepsia
Phase 1 / Phase 2CompletedUniversity of Monastir5002020-01-202025-02-25
HRZE Fasted/Fed in Newly Diagnosed TB
intravenous administration of 1st line TB drugs, day 1 - Tuberculosis
Phase 2CompletedUniversity Medical Center Groningen202013-07-012015-04-08
Residual Gastric Volume After the Ingestion of a Beverage Containing Carbohydrates Plus Whey Protein
Carbohydrate plus whey protein enriched drink - Peptic Ulcer, Gastritis
Phase 2 / Phase 3CompletedFederal University of Mato Grosso302013-02-012013-04-10
Bioavailability Study of Propranolol Under Fasting Conditions
Propranolol, Inderal-LA - To Determine Bioequivalence Under Fasting Conditions
Phase 2CompletedPar Pharmaceutical, Inc.482005-05-012008-04-04
Rapid Antidepressant Effects of Yohimbine in Major Depression
Yohimbine hydrochloride, Placebo - Depression, Involutional, Major Depresssion
Phase 2CompletedNational Institute of Mental Health (NIMH)112004-03-012019-08-29
Role of Leptin in the Neuroendocrine and Immune Response to Fasting
r-metHuLeptin, placebo - Fasting
Phase 1 / Phase 2CompletedBeth Israel Deaconess Medical Center132002-10-012017-06-07

Narrower conditions

Depression (1)  ·  Depressive Disorder, Major (1)  ·  Dyspepsia (1)  ·  Gastritis (1)  ·  Intermittent Fasting (1)  ·  Lecithin Cholesterol Acyltransferase Deficiency (1)  ·  Mood Disorders (1)  ·  Peptic Ulcer (1)  ·  Sleep Deprivation (1)  ·  Tuberculosis (1)

Broader conditions

Behavior (7)  ·  Feeding Behavior (7)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Actinomycetales Infections (1)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Behavioral Symptoms (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Depressive Disorder (1)  ·  Digestive System Diseases (1)  ·  Duodenal Diseases (1)  ·  Dyslipidemias (1)  ·  Dyssomnias (1)

Interventions

Carbohydrates (1)  ·  Esomeprazole (1)  ·  Propranolol (1)  ·  Yohimbine (1)  ·  apixaban (1)  ·  metreleptin (1)  ·  recombinant methionyl human leptin (1)

Sponsors

Beth Israel Deaconess Medical Center (1)  ·  Federal University of Mato Grosso (1)  ·  National Institute of Mental Health (NIMH) (1)  ·  Par Pharmaceutical, Inc. (1)  ·  TAHO Pharmaceuticals Ltd. (1)  ·  University Medical Center Groningen (1)  ·  University of Monastir (1)

Countries

United States (3)  ·  Brazil (1)  ·  Canada (1)  ·  Indonesia (1)  ·  Tunisia (1)

Top investigators

Carlos A Zarate, M.D. (1)  ·  Christos S Mantzoros, MD, DSc (1)  ·  Denis Audet (1)  ·  Semir Nouira, Professor (1)  ·  Tiffany A Bradley, MD (1)

Results publications

PMID 21704134, PMID 21917874, PMID 23193213, PMID 25540981, PMID 26661397, PMID 30997650, PMID 33051459, PMID 35820631, PMID 39097160, PMID 41120363

NIH funding

M01RR001032 (1), R01DK058785 (1)